BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Return on equity 2020–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
19.9%FY2025 · since FY2020: -21.9% → 19.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 19.9% | +103.6 pp |
| FY2024 | -83.7% | — |
| FY2020 | -21.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BDTX financial trends
BDTX RevenueBDTX Net incomeBDTX Net marginBDTX Gross profitBDTX Gross marginBDTX Operating incomeBDTX Operating marginBDTX Operating cash flowBDTX Free cash flowBDTX Capital expendituresBDTX Stock buybacksBDTX Dividends paidBDTX Total assetsBDTX Total liabilitiesBDTX Shareholders’ equityBDTX overview →